Distinct inflammatory mechanisms mediate early versus late colitis in mice

2002/01/01 by David M. Spencer, Geertruida M. Veldman, Subhashis Banerjee +2 · 26 citations
Biochemistry, Genetics and Molecular Biology · #Inflammatory Bowel Disease #Inflammasome and immune disorders #Gut microbiota and health

paper · pdf · doi:10.1053/gast.2002.30308

Cited by

• VEGF-C–dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease
• Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse. [europepmc]
• Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway. [europepmc]
• Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. [europepmc]
• New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. [europepmc]
• The gut microbiome in intestinal fibrosis: environmental protector or provocateur? [europepmc]
• Intestinal-specific TNFα overexpression induces Crohn's-like ileitis in mice. [europepmc]
• LPS-induced systemic inflammation is more severe in P2Y12 null mice. [europepmc]
• VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. [europepmc]
• Cytokines and mucosal immunity. [europepmc]
• Experimental Models of Inflammatory Bowel Diseases. [europepmc]
• Dietary Salt Exacerbates Experimental Colitis. [europepmc]
• Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. [europepmc]
• Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification. [europepmc]
• Inflammation and Lymphatic Function. [europepmc]
• The Role of Early Biologic Therapy in Inflammatory Bowel Disease. [europepmc]
• TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity. [europepmc]
• Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1. [europepmc]
• Bryostatin-1 ameliorated experimental colitis in Il-10 -/- Mice by protecting the intestinal barrier and limiting immune dysfunction. [europepmc]
• Early Intervention in Ulcerative Colitis: Ready for Prime Time? [europepmc]
• Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine. [europepmc]
• Specialized Pro-Resolving Mediators and the Lymphatic System. [europepmc]
• An Update of Research Animal Models of Inflammatory Bowel Disease. [europepmc]
• Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice. [europepmc]
• Omics and Multi-Omics in IBD: No Integration, No Breakthroughs. [europepmc]
• Fibrosis in IBD: from pathogenesis to therapeutic targets. [europepmc]